The announcement – which one expert said was part of a “bureaucratic fight” between HHS and FDA – states that the FDA does not require a premarket evaluation of laboratory-developed tests and this move is “part of HHS’s ongoing department-wide review. of regulatory flexibility introduced since the launch of COVID-19. …
Read More »Trump administration says FDA will no longer need premarket evaluation of certain lab tests, including some Covid-19 tests
